Plasma cytokines in acute stroke

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Plasma cytokines in acute stroke. / Christensen, Hanne Krarup; Boysen, Gudrun; Christensen, Erik; Johannesen, Helle Hjorth; Bendtzen, Klaus.

I: Journal of Stroke & Cerebrovascular Diseases, Bind 11, Nr. 2, 2011, s. 72-9.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Christensen, HK, Boysen, G, Christensen, E, Johannesen, HH & Bendtzen, K 2011, 'Plasma cytokines in acute stroke', Journal of Stroke & Cerebrovascular Diseases, bind 11, nr. 2, s. 72-9. https://doi.org/10.1053/jscd.2002.126688, https://doi.org/10.1053/jscd.2002.126688

APA

Christensen, H. K., Boysen, G., Christensen, E., Johannesen, H. H., & Bendtzen, K. (2011). Plasma cytokines in acute stroke. Journal of Stroke & Cerebrovascular Diseases, 11(2), 72-9. https://doi.org/10.1053/jscd.2002.126688, https://doi.org/10.1053/jscd.2002.126688

Vancouver

Christensen HK, Boysen G, Christensen E, Johannesen HH, Bendtzen K. Plasma cytokines in acute stroke. Journal of Stroke & Cerebrovascular Diseases. 2011;11(2):72-9. https://doi.org/10.1053/jscd.2002.126688, https://doi.org/10.1053/jscd.2002.126688

Author

Christensen, Hanne Krarup ; Boysen, Gudrun ; Christensen, Erik ; Johannesen, Helle Hjorth ; Bendtzen, Klaus. / Plasma cytokines in acute stroke. I: Journal of Stroke & Cerebrovascular Diseases. 2011 ; Bind 11, Nr. 2. s. 72-9.

Bibtex

@article{08cbbc2a5db9401d8d20bd9524e051ad,
title = "Plasma cytokines in acute stroke",
abstract = "GOALS: The aim of this study was to test the relations between plasma cytokines and the clinical characteristics, course, and risk factors in acute stroke.PATIENTS AND METHODS: The analysis was based on 179 patients with acute stroke included within 24 hours of stroke onset. On inclusion and 3 months later plasma levels of interleukin 1 beta (IL-1beta), tumor necrosis factor alpha (TNF-alpha), interleukin-1 receptor antagonist (IL-1RA), interleukin 6 (IL-6), interleukin 10 (IL-10), soluble tumor necrosis factor receptor 1 (sTNF-R1), and soluble tumor necrosis factor receptor 2 (sTNF-R2) were measured by enzyme-linked immunoassay (ELISA).FINDINGS: The levels of most cytokines were significantly different in acute stroke from the levels 3 months later; but only IL-10 was positively associated with stroke severity. C-reactive protein and white blood cell count were positively associated with the cytokine response.CONCLUSIONS: We found a substantial overall cytokine reaction that reflected the stroke incident. However, these results do not, at present, suggest a potential for clinical use, as they do not seem to add to the information obtained from the clinical workup of the individual patient.",
author = "Christensen, {Hanne Krarup} and Gudrun Boysen and Erik Christensen and Johannesen, {Helle Hjorth} and Klaus Bendtzen",
year = "2011",
doi = "10.1053/jscd.2002.126688",
language = "English",
volume = "11",
pages = "72--9",
journal = "Journal of Stroke & Cerebrovascular Diseases",
issn = "1052-3057",
publisher = "W.B.Saunders Co.",
number = "2",

}

RIS

TY - JOUR

T1 - Plasma cytokines in acute stroke

AU - Christensen, Hanne Krarup

AU - Boysen, Gudrun

AU - Christensen, Erik

AU - Johannesen, Helle Hjorth

AU - Bendtzen, Klaus

PY - 2011

Y1 - 2011

N2 - GOALS: The aim of this study was to test the relations between plasma cytokines and the clinical characteristics, course, and risk factors in acute stroke.PATIENTS AND METHODS: The analysis was based on 179 patients with acute stroke included within 24 hours of stroke onset. On inclusion and 3 months later plasma levels of interleukin 1 beta (IL-1beta), tumor necrosis factor alpha (TNF-alpha), interleukin-1 receptor antagonist (IL-1RA), interleukin 6 (IL-6), interleukin 10 (IL-10), soluble tumor necrosis factor receptor 1 (sTNF-R1), and soluble tumor necrosis factor receptor 2 (sTNF-R2) were measured by enzyme-linked immunoassay (ELISA).FINDINGS: The levels of most cytokines were significantly different in acute stroke from the levels 3 months later; but only IL-10 was positively associated with stroke severity. C-reactive protein and white blood cell count were positively associated with the cytokine response.CONCLUSIONS: We found a substantial overall cytokine reaction that reflected the stroke incident. However, these results do not, at present, suggest a potential for clinical use, as they do not seem to add to the information obtained from the clinical workup of the individual patient.

AB - GOALS: The aim of this study was to test the relations between plasma cytokines and the clinical characteristics, course, and risk factors in acute stroke.PATIENTS AND METHODS: The analysis was based on 179 patients with acute stroke included within 24 hours of stroke onset. On inclusion and 3 months later plasma levels of interleukin 1 beta (IL-1beta), tumor necrosis factor alpha (TNF-alpha), interleukin-1 receptor antagonist (IL-1RA), interleukin 6 (IL-6), interleukin 10 (IL-10), soluble tumor necrosis factor receptor 1 (sTNF-R1), and soluble tumor necrosis factor receptor 2 (sTNF-R2) were measured by enzyme-linked immunoassay (ELISA).FINDINGS: The levels of most cytokines were significantly different in acute stroke from the levels 3 months later; but only IL-10 was positively associated with stroke severity. C-reactive protein and white blood cell count were positively associated with the cytokine response.CONCLUSIONS: We found a substantial overall cytokine reaction that reflected the stroke incident. However, these results do not, at present, suggest a potential for clinical use, as they do not seem to add to the information obtained from the clinical workup of the individual patient.

U2 - 10.1053/jscd.2002.126688

DO - 10.1053/jscd.2002.126688

M3 - Journal article

C2 - 17903860

VL - 11

SP - 72

EP - 79

JO - Journal of Stroke & Cerebrovascular Diseases

JF - Journal of Stroke & Cerebrovascular Diseases

SN - 1052-3057

IS - 2

ER -

ID: 34060665